Publicaciones en colaboración con investigadores/as de Hospital Universitario HM Montepríncipe (31)

2023

  1. Cardiovascular and renal health: Preeclampsia as a risk marker

    Nefrologia, Vol. 43, Núm. 3, pp. 269-280

  2. Heart Failure in the Elderly: the Role of Biological and Sociocultural Aspects Related to Sex

    Current Heart Failure Reports, Vol. 20, Núm. 5, pp. 321-332

  3. Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  4. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2022

  1. Bone marrow activation in response to metabolic syndrome and early atherosclerosis

    European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828

  2. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  3. Functional trajectories associated with acute illness and hospitalization in oldest old patients: Impact on mortality

    Frontiers in Physiology, Vol. 13

  4. Impact of Gestational COVID-19 on Neonatal Outcomes: Is Vertical Infection Possible?

    The Pediatric infectious disease journal, Vol. 41, Núm. 6, pp. 466-472

  5. Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 357-361

  6. New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135

  7. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

2020

  1. Association Between Body Size Phenotypes and Subclinical Atherosclerosis

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 12

  2. Development of a predictive model for hospital mortality and re-admission in a cohort of infected patients that require hospitalization

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 5, pp. 350-357

2019

  1. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1371-1382

2018

  1. Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions

    Gastroenterologia y Hepatologia

2017

  1. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis

    Catheterization and Cardiovascular Interventions, Vol. 90, Núm. 5, pp. 809-816

  2. Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy

    International Journal of Cardiology, Vol. 228, pp. 828-833

  3. Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score

    Journal of the American College of Cardiology, Vol. 70, Núm. 20, pp. 2463-2473